SIBN - SI-BONE, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Santa Clara,
United States
Type: Equity
SIBN price evolution
SIBN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $25.58 | $32.04 | $33.27 | |
| Short term investments | $125.95 | $125.78 | $132.75 | |
| Net receivables | $24.91 | $24.8 | $22.11 | $21.95 |
| Inventory | $25.52 | $23.23 | $21.05 | $20.25 |
| Total current assets | $203.7 | $202.33 | $203.63 | $211.39 |
| Long term investments | ||||
| Property, plant & equipment | $22.97 | $21.19 | $19.76 | $18.71 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $21.51 | $20.09 | $19.03 | |
| Total investments | $125.95 | $125.78 | $132.75 | |
| Total assets | $227 | $223.84 | $223.71 | $230.43 |
| Current liabilities | ||||
| Accounts payable | $7.32 | $7.18 | $7.66 | $4.59 |
| Deferred revenue | ||||
| Short long term debt | $1.38 | $1.43 | $1.42 | |
| Total current liabilities | $24.68 | $22.06 | $20.86 | $23.46 |
| Long term debt | $36.19 | $37.04 | $37.3 | $37.58 |
| Total noncurrent liabilities | $37.05 | $37.31 | $37.59 | |
| Total debt | $38.42 | $38.73 | $38.99 | |
| Total liabilities | $62.02 | $59.11 | $58.18 | $61.05 |
| Shareholders' equity | ||||
| Retained earnings | -$426.86 | -$420.28 | -$411.35 | -$400.44 |
| Other shareholder equity | $0.58 | $0.23 | $0.27 | $0.34 |
| Total shareholder equity | $164.73 | $165.54 | $169.38 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $33.27 | $20.72 | $63.42 | $53.58 |
| Short term investments | $132.75 | $76.57 | $83.56 | $142.85 |
| Net receivables | $21.95 | $20.67 | $14.25 | $13.61 |
| Inventory | $20.25 | $17.28 | $11.5 | $5.63 |
| Total current assets | $211.39 | $137.61 | $175.87 | $218.24 |
| Long term investments | ||||
| Property, plant & equipment | $18.71 | $19.57 | $14.24 | $4.53 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $19.03 | $19.94 | $14.64 | $4.9 |
| Total investments | $132.75 | $76.57 | $83.56 | $142.85 |
| Total assets | $230.43 | $157.55 | $190.51 | $223.14 |
| Current liabilities | ||||
| Accounts payable | $4.59 | $6.28 | $3.2 | $3.27 |
| Deferred revenue | ||||
| Short long term debt | $1.42 | $1.39 | $1.34 | |
| Total current liabilities | $23.46 | $21.18 | $16.89 | $13.47 |
| Long term debt | $37.58 | $35.17 | $39.14 | $39.45 |
| Total noncurrent liabilities | $37.59 | $38.07 | $39.2 | $40.31 |
| Total debt | $38.99 | $39.43 | $40.48 | $39.45 |
| Total liabilities | $61.05 | $59.25 | $56.09 | $53.78 |
| Shareholders' equity | ||||
| Retained earnings | -$400.44 | -$357.11 | -$295.85 | -$239.28 |
| Other shareholder equity | $0.34 | $0.23 | $0.35 | $0.52 |
| Total shareholder equity | $169.38 | $98.3 | $134.42 | $169.36 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $40.34 | $39.97 | $37.87 | $38.86 |
| Cost of revenue | $8.39 | $8 | $10.18 | |
| Gross Profit | $31.9 | $31.58 | $29.86 | $28.68 |
| Operating activities | ||||
| Research & development | $4.35 | $4.34 | $4.16 | |
| Selling, general & administrative | $37.3 | $37.56 | $37.02 | |
| Total operating expenses | $39.54 | $41.65 | $41.91 | $41.18 |
| Operating income | -$10.08 | -$12.04 | -$12.51 | |
| Income from continuing operations | ||||
| EBIT | -$8.06 | -$10.02 | -$10.09 | |
| Income tax expense | ||||
| Interest expense | $1.05 | $0.88 | $0.88 | $0.89 |
| Net income | ||||
| Net income | -$6.58 | -$8.94 | -$10.9 | -$10.98 |
| Income (for common shares) | -$8.94 | -$10.9 | -$10.98 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $138.89 | $106.41 | $90.15 | $73.39 |
| Cost of revenue | $29.47 | $15.71 | $10.43 | $8.9 |
| Gross Profit | $109.42 | $90.7 | $79.72 | $64.48 |
| Operating activities | ||||
| Research & development | $15.03 | $13.63 | $12.44 | $9.46 |
| Selling, general & administrative | $141.32 | $136.69 | $118.95 | $93.59 |
| Total operating expenses | $156.35 | $150.31 | $131.39 | $103.05 |
| Operating income | -$46.93 | -$59.61 | -$51.67 | -$38.57 |
| Income from continuing operations | ||||
| EBIT | -$39.87 | -$58.44 | -$51.21 | -$37.6 |
| Income tax expense | ||||
| Interest expense | $3.46 | $2.82 | $5.37 | $6.1 |
| Net income | ||||
| Net income | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| Income (for common shares) | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$8.94 | -$10.9 | -$10.98 | |
| Operating activities | ||||
| Depreciation | $0.99 | $1.09 | $1.57 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.4 | $7.03 | $5.94 | |
| Total cash flows from operations | -$6.33 | -$7.57 | -$2.3 | |
| Investing activities | ||||
| Capital expenditures | -$3.11 | -$2.08 | -$1.09 | |
| Investments | $1.28 | $8.43 | -$17.82 | |
| Total cash flows from investing | $8.29 | -$1.83 | $6.35 | -$18.91 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.78 | $0.1 | $0.84 | |
| Net borrowings | ||||
| Total cash flows from financing | $2.04 | $1.78 | $0.1 | $0.84 |
| Effect of exchange rate | $0.23 | -$0.07 | -$0.11 | $0.15 |
| Change in cash and equivalents | -$3.05 | -$6.46 | -$1.23 | -$20.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$43.34 | -$61.26 | -$56.57 | -$43.7 |
| Operating activities | ||||
| Depreciation | $5.43 | $3.45 | $2.09 | $1.13 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $24.06 | $23.06 | $16.87 | $11.93 |
| Total cash flows from operations | -$18.71 | -$41.66 | -$39.53 | -$30.66 |
| Investing activities | ||||
| Capital expenditures | -$7.8 | -$9.51 | -$6.39 | -$2.56 |
| Investments | -$52 | $6.69 | $57.97 | -$60.35 |
| Total cash flows from investing | -$59.8 | -$2.81 | $51.58 | -$62.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $90.25 | $2.2 | $4.91 | $137.99 |
| Net borrowings | $0.69 | -$6.62 | -$1.59 | |
| Total cash flows from financing | $90.93 | $2.2 | -$1.71 | $136.4 |
| Effect of exchange rate | $0.13 | -$0.43 | -$0.5 | $0.32 |
| Change in cash and equivalents | $12.55 | -$42.7 | $9.84 | $43.15 |
News
Fundamentals
| Market cap | $513.60M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 41.79M |
| Revenue | $157.03M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$37.40M |
| Revenue Q/Q | 18.60% |
| Revenue Y/Y | 18.98% |
| P/E ratio | -13.73 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 3.27 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.89 |
|---|---|
| ROA | -16.53% |
| ROE | N/A |
| Debt/Equity | 0.36 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 8.25 |
| Quick ratio | 7.22 |